AblaCare
Business Services · France · 1-10 Employees
View Company Info for Free
Overview
Headquarters
18 Rue Du Quatre Septembre, Paris, Ile-d...Website
www.ablacare.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About AblaCare
May Health is a company focused on developing a modern treatment for polycystic ovary syndrome (PCOS) called Ovarian Rebalancing, which aims to restore ovulation through targeted ovarian ablation. This investigational treatment requires no hormones and is designed for outpatient use. Currently in the clinical trial stage, May Health is working to gain FDA approval in the US and a CE Mark in Europe to make their treatment available to patients. Their goal is to provide effective solutions for individuals struggling with PCOS.Explore more
AblaCare Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AblaCare your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if AblaCare is spiking on competitors!
Earning: See what the market has to say on AblaCare recently announced quarterly report
Click to see if AblaCare had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at AblaCare
AblaCare, which may be a good buyer, showed buying intent in Masked Content Topic
Check if AblaCare has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once AblaCare has new funding data
Product Launch: Get notified when AblaCare launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined AblaCare as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
AblaCare is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AblaCare is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AblaCare.
AblaCare financials insights
Gather financial insights about AblaCare, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$8.1M
AblaCare Tech Stack
A closer look at the technologies used by AblaCare
See more technologies
AblaCare News & Media
AblaCare Announces Series A Financing of €10 Million by Sofinnova Partners for Innovative Infertility Treatment and Appoints Jodie Fam as CEO
PARIS--(BUSINESS WIRE)--AblaCare, a medical device company dedicated to transforming women’s health and fertility care, announced today that it has raised €10 million in Series A financing from Sofinnova Partners. The company also announced the appointment of seasoned medical device executive Jodie Fam as CEO. AblaCare’s treatment, a minimally invasive procedure called “ovarian rebalancing,” uses ablation to restore ovulation in women with infertility related to polycystic ovary syndrome (PCOS)
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding AblaCare
Sign Up For FreeTo access detailed company insights
May Health is a company focused on developing a modern treatment for polycystic ovary syndrome (PCOS) called Ovarian Rebalancing, which aims to restore ovulation through targeted ovarian ablation. This investigational treatment requires no hormones and is designed for outpatient use. Currently in the clinical trial stage, May Health is working to g... Read More
